Twenty-five patients were treated with intensive chemotherapy for small cell carcinoma of
the lung. Twelve patients received concurrent urokinase and combination chemotherapy in …

Abstract Background and Methods. Fifty‐one patients with small cell lung cancer (SCLC)
were treated with alternating urokinase (UK)‐cyclophosphamide‐doxorubicin (Adriamycin …

Urokinase-type plasminogen activator has been administered by other investigators to
patients with small cell carcinoma of the lung (SCCL) in an attempt to induce lysis of fibrin …

Treatment of small cell carcinoma of the lung (SCCL) has long been a challenge for
physicians, owing to its rapid growth, propensity for distant spread evident frequently at …

Fifty-four patients with localized and extensive small cell carcinoma of the lung and no prior
therapy were treated with intensive induction chemotherapy. The induction regimen …

Abstract From September 1973 to October 1974, 34 patients with small cell carcinoma of the
lung were treated with monthly courses of BCVP: BCNU 60 mg/M 2 iv, cyclophosphamide …

Despite response rates to combination chemotherapy regimens approaching 90 per cent,
long-term survival is experienced by less than 10 per cent of patients with small cell …

Fifteen patients with extensive small cell carcinoma of the lung and no prior therapy were
treated with a chemotherapeutic regimen similar in intensity to the approach used in acute …

S MALL CELL lung cancer (SCLC) represents about 25% to 30% of all lung cancers,
accounting for approximately 30,000 deaths in 1986.1 Its clinical biology differs from the …

Thirty‐seven patients with small cell carcinoma of the lung and no prior chemotherapy were
treated with a program involving the alternation of two three‐drug regimens, each composed …